PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $154,207 | -42.5% | 9,245 | -4.8% | 0.00% | 0.0% |
| Q2 2023 | $268,190 | +14.8% | 9,710 | -4.4% | 0.00% | 0.0% |
| Q1 2023 | $233,680 | +150.9% | 10,160 | +19.0% | 0.00% | – |
| Q4 2022 | $93,128 | +52.7% | 8,536 | +18.6% | 0.00% | – |
| Q3 2022 | $61,000 | +7.0% | 7,199 | 0.0% | 0.00% | – |
| Q2 2022 | $57,000 | -66.5% | 7,199 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $170,000 | -20.9% | 7,199 | +14.4% | 0.00% | 0.0% |
| Q4 2021 | $215,000 | +400.0% | 6,293 | +159.1% | 0.00% | – |
| Q3 2021 | $43,000 | – | 2,429 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |